TABLE 1.
Eq. | Sampling | α × 10−2 [mol/kcal] | β × 10−2 [mol/kcal] | γ × 10−2 [Å−2] | κ | SD | r2 | RMSE |
||
---|---|---|---|---|---|---|---|---|---|---|
LNOb | LOOc | LSOd | ||||||||
1a | minimization | - | - | 1.566 ± 0.350 | −14.30 ± 0.98 | 1.128 | 0.435 | 1.646 | 1.785 | 1.750 |
1 | MD (200 ps) | - | - | 1.656 ± 0.251 | −11.75 ± 1.04 | 1.101 | 0.627 | 1.338 | 1.469 | 1.478 |
4 | MD (8×25 ps) | 1.639 ± 0.421 | 2.231 ± 0.649 | 1.121 ± 0.235 | −5.785 ± 1.588 | 0.862 | 0.845 | 0.931 | 1.008 | 1.012 |
No conformational sampling, just the minimized ligand structures used.
No omission of compounds.
Leave-one-out cross-validation.
Leave-several-out cross-validation: random selection of a 6-member test set, repeated 200 times.